Mendelian randomization: Genetic variants as instruments for strengthening causal inference in observational studies

Biosocial Surveys

Volumn , Issue , 2008, Pages 336-366

  Davey Smith, George ^a,b,c   Ebrahim, Shah ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85009317139     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/11939     Document Type: Chapter

References (111)

1. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 33 0, 1029-1035.
2. Baird, P. (2000). Genetic technologies and achieving health for populations. International Journal of Health Services, 30, 407-424.
3. Beral, V., Banks, E., and Reeves, G. (2002). Evidence from randomized trials of the long-term effects of hormone replacement therapy. Lancet, 36 0, 942-944.
4. Berkowitz, A. (1996). Our genes, ourselves? Bioscience, 46 , 42-51.
5. Bhatti, P., Sigurdson, A.J., Wang, S.S., Chen, J., Rothman, N., Hartge, P., Bergen, A.W., and Landi, M.T. (2005). Genetic variation and willingness to participate in epidemiological research: Data from three studies. Cancer Epidemiology Biomarkers and Prevention, 14 , 2449-2453.
6. Bolon, B., and Galbreath, E. (2002). Use of genetically engineered mice in drug discovery and development: Wielding Occam's razor to prune the product portfolio. International Journal of Toxicology, 21 , 55-64.
7. Bovet, P., and Paccaud, F. (2001). Alcohol, coronary heart disease, and public health: Which evidence-based policy? International Journal of Epidemiology, 30, 734-737.
8. Burr, M.L., Fehily, A.M., Butland, B.K., Bolton, C.H., and Eastham, R.D. (1986). Alcohol and high-density-lipoprotein cholesterol: A randomised controlled trial. British Journal of Nutrition, 56 , 81-86.
9. Cardon, L.R., and Bell, J.I. (2001). Association study designs for complex diseases. Nature Reviews: Genetics, 2, 91-99.
10. Casas, J.P., et al. (2006). Insight into the nature of the CRP-coronary event association using Mendelian randomization. International Journal of Epidemiology, 35 , 922-931.
11. Chao, Y.-C., Liou, S.-R., Chung, Y.-Y., Tang, H.-S., Hsu, C.-T., Li, T.-K., and Yin, S.-J. (1994). Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology, 19 , 360-366.
12. Chatterjee, N., Kalaylioglu, Z., and Carroll, R.J. (2005). Exploiting gene-environment independence in family-based case-control studies: Increased power for detecting associations, interactions, and joint effects. Genetic Epidemiology, 28 , 138-156.
13. Clayton, D., and McKeigue, P.M. (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet, 358 , 1356-1360.
14. Colhoun, H., McKeigue, P.M., and Davey Smith, G. (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361 , 865-872.
15. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G.D.O., Pepys, M.B., and Gudnason, V. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 35 0, 1387-1397.
16. Davey Smith, G. (2006). Cochrane lecture: Randomised by (your) god: Robust inference from an observational study design. Journal of Epidemiology and Community Health, 60, 382-388.
17. Davey Smith, G., and Ebrahim, S. (2002). Data dredging, bias, or confounding (editorial). British Medical Journal, 325 , 1437-1438.
18. Davey Smith, G., and Ebrahim, S. (2003). Mendelian randomization: Can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology, 32 , 1-22.
19. Davey Smith, G., and Ebrahim, S. (2004). Mendelian randomization: Prospects, potentials, and limitations. International Journal of Epidemiology, 33 , 30-42.
20. Davey Smith, G., and Ebrahim, S. (2005). What can Mendelian randomization tell us about modifiable behavioural and environmental exposures? British Medical Journal, 33 0, 1076-1079.
21. Davey Smith, G., Harbord, R., Milton, J., Ebrahim, S., and Sterne, J.A.C. (2005a). Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 , 2228-2233.
22. Davey Smith, G., Lawlor, D., Harbord, R., Timpson, N., Rumley, A., Lowe, G., Day, I., and Ebrahim, S. (2005b). Association of C-reactive protein with blood pressure and hypertension: Lifecourse confounding and Mendelian randomization tests of causality. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 , 1051-1056.
23. Davey Smith, G., Lawlor, D., Harbord, R., Timpson, N., Day, I., and Ebrahim, S. (2007). Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology. Public Library of Science Medicine.
24. Davey Smith, G., and Phillips, A.N. (1996). Inflation in epidemiology: The proof and measurement of association between two things revisited. British Medical Journal, 312 , 1659-1661.
25. Debat, V., and David, P. (2001). Mapping phenotypes: Canalization, plasticity, and developmental stability. Trends in Ecology and Evolution, 16 , 555-561.
26. Delanghe, J., Langlois, M., Duprez, D., De Buyzere, M., and Clement, D. (1999). Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis, 145 , 287-292.
27. Didelez, V., and Sheehan, N.A. (2007). Mendelian randomization: Why epidemiology needs a formal language for causality. In F. Russo and J. Williamson (Eds.), Causality and Probability in the Sciences (pp. 1-30). London: College Publications.
28. Eichner, J.E., Dunn, S.T., Perveen, G., Thompson, D.M., Stewart, K.E., and Stroehla, B.C. (2002). Apolipoprotein E polymorphism and cardiovascular disease: A HuGE Review. American Journal of Epidemiology, 155 , 487-495.
29. Eidelman, R.S., Hollar, D., Hebert, P.R., Lamas, G.A., and Hennekens, C.H. (2004). Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Archives of Internal Medicine, 164 , 1552-1556.
30. Enomoto, N., Takase, S., Yasuhara, M., and Takada, A. (1991). Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcoholism: Clinical and Experimental Research, 15 , 141-144.
31. Erichsen, H.C., Eck, P., Levine, M., and Chanock, S. (2001). Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23 A2). Journal of Nutrition, 131 , 2623-2627.
32. Ewbank, D. (2001). Demography in the age of genomics: A first look at the prospects. In National Research Council, Cells and surveys: Should biological measures be included in social science research? (pp. 64-109), Committee on Population, C.E. Finch, J.E. Vaupel, and K. Kinsella (Eds.). Washington, DC: National Academy Press.
33. Garcia-Closas, M., et al. (2005). NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366 , 649-659.
34. Gause, G.F. (1942). The relation of adaptability to adaptation. Quarterly Review of Biology, 17 , 99-114.
35. Gerlai, R. (2001). Gene targeting: Technical confounds and potential solutions in behavioural and brain research. Behavioural Brain Research, 125 , 13-21.
36. Gibson, G., and Wagner, G. (2000). Canalization in evolutionary genetics: A stabilizing theory? BioEssays, 22 , 372-380.
37. Glebart, W.M. (1998). Databases in genomic research. Science, 282 , 659-661.
38. Glynn, R.K. (2006). Commentary: Genes as instruments for evaluation of markers and causes. International Journal of Epidemiology, 35 , 932-934.
39. Goldschmidt, R.B. (1938). Physiological genetics. New York: McGraw Hill.
40. Gu, Z., Steinmetz, L.M., Gu, X., Scharfe, C., Davis, R.W., and Li, W.-H. (2003). Role of duplicate genes in genetic robustness against null mutations. Nature, 421 , 63-66.
41. Han, T.S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M.E., and Haffner, S.M. (2002). Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care, 25 , 2016-2021.
42. Hart, C., Davey Smith, G., Hole, D., and Hawthorne, V. (1999). Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: Results from a prospective cohort study of Scottish men with 21 years of follow up. British Medical Journal, 318 , 1725-1729.
43. Hartman, J.L., Garvik, B., and Hartwell, L. (2001). Principles for the buffering of genetic variation. Science, 291 , 1001-1004.
44. Hasin, D., Aharonovich, E., Liu, X., Mamman, Z., Matseoane, K., Carr, L., and Li, T.K. (2002). Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and recent Russian immigrants. American Journal of Psychiatry, 159 (8), 1432-1434.
45. Haskell, W.L., Camargo, C., Williams, P.T., Vranizan, K.M., Krauss, R.M., Lindgren, F.T., and Wood, P.D. (1984). The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. New England Journal of Medicine, 31 0, 805-810.
46. Heart Protection Study Collaborative Group. (2002). MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 36 0, 23-33.
47. Higuchi, S., Matsushita, S., Imazeki, H., Kinoshita, T., Takagi, S., and Kono, H. (1994). Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet, 343 , 741-742.
48. Hirschfield, G.M., and Pepys, M.B. (2003). C-reactive protein and cardiovascular disease: New insights from an old molecule. Quarterly Journal of Medicine, 9, 793-807.
49. Holtzman, N.A. (2001). Putting the search for genes in perspective. International Journal of Health Services, 31 , 445.
50. Hornstein, E., and Shomron, N. (2006). Canalization of development by microRNAs. Nature Genetics, 38 , S20-S24.
51. Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N., and Manson, J.E. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53 , 693-700.
52. Jablonka-Tavory, E. (1982). Genocopies and the evolution of interdependence. Evolutionary Theory, 6, 167-170.
53. Jousilahti, P., and Salomaa, V. (2004). Fibrinogen, social position, and Mendelian randomisation. Journal of Epidemiology and Community Health, 58 , 883.
54. Kaplan, J.M., and Pigliucci, M. (2001). Genes "for" phenotypes: A modern history view. Biology and Philosophy, 16 , 189-213.
55. Keavney, B., Danesh, J., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R., and Collins, R. (2006). The International Studies of Infarct Survival (ISIS) collaborators. Fibrinogen and coronary heart disease: Test of causality by Mendelian randomization. International Journal of Epidemiology, 35 , 935-943.
56. Keavney, B., Palmer, A., Parish, S., Clark, S., Youngman, L., Danesh, J., McKenzie, C., Delépine, M., Lathrop, M., Peto, R., and Collins, R. (2004). Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: Discrepancies between genotype, blood lipid concentrations, and coronary disease risk. International Journal of Epidemiology, 33 , 1002-1013.
57. Kitami, T., and Nadeau, J.H. (2002). Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication. Nature Genetics, 32 , 191-194.
58. Klatsky, A.L. (2001). Commentary: Could abstinence from alcohol be hazardous to your health? International Journal of Epidemiology, 30, 739-742.
59. Lancet. (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 354 (9177), 447-455.
60. Langlois, M.R., Delanghe, J.R., De Buyzere, M.L., Bernard, D.R., and Ouyang, J. (1997). Effect of haptoglobin on the metabolism of vitamin C. American Journal of Clinical Nutrition, 66 , 606-610.
61. Lawlor, D.A., Harbord, R.M., Sterne, J.A.C., and Davey Smith, G. (2007). Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Statistics in Medicine.
62. Little, J., and Khoury, M.J. (2003). Mendelian randomization: A new spin or real progress? Lancet, 362 , 930-931.
63. Manson, J., Stampfer, M.J., Willett, W.C., Colditz, G., Rosner, B., Speizer, F.E., and Hennekens, C.H. (1991). A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation, 84 (Suppl. II), 546.
64. Marmot, M. (2001). Reflections on alcohol and coronary heart disease. International Journal of Epidemiology, 30, 729-734.
65. Morange, M. (2001). The misunderstood gene. Cambridge, MA: Harvard University Press.
66. Morgan, T.H. (1935). The relation of genetics to physiology and medicine. Scientific Monthly, 41 , 5-18.
67. Mucci, L.A., Wedren, S., Tamimi, R.M., Trichopoulos, D., and Adami, H.O. (2001). The role of gene-environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung, and breast. Journal of Internal Medicine, 249 , 477-493.
68. National Research Council (2001). Cells and surveys. Should biological measures be included in Social Science Research? Committee on Population, C.E. Finch, J.E. Vaupel, and K. Kinsella (Eds.). Washington, DC: National Academy Press.
69. Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., Barnhart, S., and Hammar, S. (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine, 334 , 1150-1155.
70. Osganian, S.K., Stampfer, M.J., Rimm, E., Spiegelman, D., Hu, F.B., Manson, J.E., and Willett, W.C. (2003). Vitamin C and risk of coronary heart disease in women. Journal of the American College of Cardiology, 42 , 246-252.
71. Osier, M.V., Pakstis, A.J., Soodyall, H., Comas, D., Goldman, D., Odunsi, A., Okonofua, F., Parnas, J., Schulz, L.O., Bertranpetit, J., Bonne-Tamir, B., Lu, R.-B., Kidd, J.R., and Kidd, K.K. (2002). A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. American Journal of Human Genetics, 71 , 84-99.
72. Palmer, L., and Cardon, L. (2005). Shaking the tree: Mapping complex disease genes with linkage disequilibrium. Lancet, 366 , 1223-1234.
73. Perera, F.P. (1997). Environment and cancer: Who are susceptible? Science, 278 , 1068-1073.
74. Pimstone, S.N., Sun, X.-M., du Souich, C., Frohlich, J.J., Hayden, M.R., and Soutar, A.K. (1998). Phenotypic variation in heterozygous familial hypercholesterolaemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 18 , 309-315.
75. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, 286 , 327-334.
76. Ridker, P.M., Cannon, C.P., Morrow, D., Rifai, N., Rose, L.M., McCabe, C.H., Pfeffer, M.A., Braunwald, E. (2005). C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352 , 20-28.
77. Rimm, E. (2001). Commentary: Alcohol and coronary heart disease-Laying the foundation for future work. International Journal of Epidemiology, 30, 738-739.
78. Rimm, E.B., Stampfer, M.J., Ascherio, A., Giovannucci, E., Colditz, G.A., and Willett, W.C. (1993). Vitamin E consumption and the risk of coronary heart disease in men. New England Journal of Medicine, 328 , 1450-1456.
79. Rose, S. (1995). The rise of neurogenetic determinism. Nature, 373 , 380-382.
80. Rutherford, S.L. (2000). From genotype to phenotype: Buffering mechanisms and the storage of genetic information. BioEssays, 22 , 1095-1105.
81. Sesso, D., Buring, J.E., Rifai, N., Blake, G.J., Gaziano, J.M., and Ridker, P.M. (2003). C-reactive protein and the risk of developing hypertension. Journal of the American Medical Association, 29 0, 2945-2951.
82. Shaper, A.G. (1993). Editorial: Alcohol, the heart, and health. American Journal of Public Health, 83 , 799-801.
83. Shastry, B.S. (1998). Gene disruption in mice: Models of development and disease. Molecular and Cellular Biochemistry, 181 , 163-179.
84. Sijbrands, E.J.G., Westengorp, R.G.J., Defesche, J.C., De Meier, P.H.E.M., Smelt, A.H.M., and Kastelein, J.J.P. (2001). Mortality over two centuries in large pedigree with familial hypercholesterolaemia: Family tree mortality study. British Medical Journal, 322 , 1019- 1023.
85. Sjöholm, A., and Nyström, T. (2005). Endothelial inflammation in insulin resistance. Lancet, 365 , 610-612.
86. Smith, J. (2002). Apolipoproteins and aging: Emerging mechanisms. Ageing Research Reviews, 1, 345-365.
87. Smits, K.M., et al. (2004). Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. International Journal of Cancer, 11 0(2), 266-270.
88. Song, Y., Stampfer, M.J., and Liu, S. (2004). Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Annals of Internal Medicine, 137-147.
89. Spearman, C. (1904). The proof and measurement of association between two things. American Journal of Psychology, 15 , 72-101.
90. Stampfer, M.J., and Colditz, G.A. (1991). Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventative Medicine, 20, 47-63.
91. Stampfer, M.J., Hennekens, C.H., Manson, J.E., Colditz, G.A., Rosner, B., and Willett, W.C. (1993). Vitamin E consumption and the risk of coronary disease in women. New England Journal of Medicine, 328 , 1444-1449.
92. Strohman, R.C. (1993). Ancient genomes, wise bodies, unhealthy people: The limits of a genetic paradigm in biology and medicine. Perspectives in Biology and Medicine, 37 , 112-145.
93. Takagi, S., Iwai, N., Yamauchi, R., Kojima, S., Yasuno, S., Baba, T., Terashima, M., Tsutsumi, Y., Suzuki, S., Morii, I., Hanai, S., Ono, K., Baba, S., Tomoike, H., Kawamura, A., Miyazaki, S., Nonogi, H., and Goto, Y. (2002). Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertension Research, 25 , 677-681.
94. Terwilliger, J.D., and Weiss, W.M. (2003). Confounding, ascertainment bias, and the blind quest for a genetic fountain of youth. Annals of Medicine, 35 , 532-544.
95. Thomas, D.C., and Conti, D.V. (2004). Commentary on the concept of Mendelian randomization. International Journal of Epidemiology, 33 , 17-21.
96. Thompson, W.D. (1991). Effect modification and the limits of biological inference from epidemiological data. Journal of Clinical Epidemiology, 44 , 221-232.
97. Timpson, N.J., Lawlor, D.A., Harbord, R.M., Gaunt, T.R., Day, I.N.M., Palmer, L.J., Hattersley, A.T., Ebrahim, S., Lowe, G.D.O., Rumley, A., and Davey Smith, G. (2005). C-reactive protein and its role in metabolic syndrome: Mendelian randomization study. Lancet, 366 , 1954-1959.
98. Tybjaerg-Hansen, A., Steffensen, R., Meinertz, H., Schnohr, P., and Nordestgaard, B.G. (1998). Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. New England Journal of Medicine, 338 , 1577-1584.
99. Umbach, D.M., and Weinberg, C.R. (1997). Designing and analysing case-control studies to exploit independence of genotype and exposure. Statistics in Medicine, 16 , 1731-1743.
100. Verma, S., Szmitko, P.E., and Ridker, P.M. (2005). C-reactive protein comes of age. Nature Clinical Practice, 2, 29-36.
101. Wacholder, S., Rothman, N., and Caporaso, N. (2000). Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. Journal of the National Cancer Institute, 92 , 1151-1158.
102. Wacholder, S., Rothman, N., and Caporaso, N. (2002). Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiology, Biomarkers and Prevention, 11 , 513-520.
103. Waddington, C.H. (1942). Canalization of development and the inheritance of acquired characteristics. Nature, 15 0, 563-565.
104. Weiss, K., and Terwilliger, J. (2000). How many diseases does it take to map a gene with SNPs? Nature Genetics, 26 , 151-157.
105. Wilkins, A.S. (1997). Canalization: A molecular genetic perspective. BioEssays, 19 , 257-262.
106. Willett, W.C. (1990). Vitamin A and lung cancer. Nutrition Reviews, 48 , 201-211.
107. Willett, W.C. (2001). Eat, drink, and be healthy: The Harvard Medical School guide to healthy eating. New York: Free Press.
108. Williams, R.S., and Wagner, P.D. (2000). Transgenic animals in integrative biology: Approaches and interpretations of outcome. Journal of Applied Physiology, 88 , 1119-1126.
109. Wright, A.F., Carothers, A.D., and Campbell, H. (2002). Gene-environment interactions: The BioBank UK study. Pharmacogenomics Journal, 2, 75-82.
110. Wolf, U. (1995). The genetic contribution to the phenotype. Human Genetics, 95 , 127-148.
111. Wu, T., Dorn, J.P., Donahue, R.P., Sempos, C.T., and Trevisan, M. (2002). Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: The Third National Health and Nutrition Examination Survey, 1988-1994. American Journal of Epidemiology, 155 , 65-71.